RAB7A and pancreatic adenocarcinoma: By comparing RAB7A expression in normal specimens in the TCGA and GTEx databases with tumour specimens in the corresponding TCGA database, RAB7A was found to be significantly highly expressed in 28 cancers (Fig. 1A), including pancreatic adenocarcinoma (PAAD) (Fig. 1B).